Patients on active chemotherapy for any type of cancer as well as people with hematologic malignancies should be prioritized to received COVID testing since those patients are almost all immunosuppressed.
People receiving hormone therapy do not have their immune systems compromised and are not at an increased risk because they are taking a hormone therapy drug (listen to the interview “A Vital Video About Prostate Cancer,” we posted on the COVID-19 Papers.
